BofA raised the firm’s price target on Eastman Chemical (EMN) to $75 from $74 and keeps a Buy rating on the shares. 2026 earnings tailwinds such as cost savings and an asset utilization ramp are material enough to lead to earnings improvement from 2025, even if end-market demand remains sluggish and the company continues to focus on cash generation at the expense of profits, the analyst tells investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
